OBLIMERSEN SODIUM
UNII SH55B0RQ9K

Substance Identification & Data

This profile provides standardized clinical and technical data for Oblimersen Sodium, uniquely identified by the FDA Unique Ingredient Identifier (UNII) SH55B0RQ9K.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

SH55B0RQ9K

CAS Registry Number

N/A

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

OBLIMERSEN SODIUM

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C66722

National Cancer Institute reference terminology for clinical and research data.

USAN ID

NN-70

Identifier assigned by the United States Adopted Names Council.

Substance Type

nucleicAcid

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Oblimersen Sodium. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.